Company Profile
- Stock Code
- VKTX
- ISIN Code
- US92686J1060
- Currency
- US Dollar (USD)
- IPO Date
- 2015-04-29

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients wit...